Pfizer and BioNTech exercised legal authorization to use their patent until May 2023. The court made a decision that Moderna legally withdrew their consent in March 2022 so their previous patent ...

The EU Court ruled against the Commission for failing to justify its refusal to release texts between von der Leyen and Pfizer’s CEO. Critics say the Commission’s actions undermine public ...

Pfizer and BioNTech won a round in their legal battle with Moderna over COVID-19 vaccine patents on Wednesday, convincing a U.S. Patent Office tribunal that two patents Moderna accused them of ...

Brian Coleman, Head of Enterprise Information Security at Pfizer, and winner of the Legalweek Leaders in Tech Law Award for Best Use of Artificial Intelligence which won the Best Use of Artificial ...

The constellation of conservative activists who have led a decades-long legal battle against affirmative action suffered a minor setback last week that nevertheless offers vital insight into the ...

Pfizer and Moderna continue their legal battle over COVID-19 vaccine patents after a mixed ruling by London's High Court, with potential appeals and significant financial stakes involved.

Pfizer's Direct Copay Assistance Program was designed to limit tafamidis cost-sharing to $35 a month for Medicare Part D enrollees with lower incomes.

Moderna and Pfizer/BioNTech earned more than $110 billion from their COVID vaccines. Read how patent infringement cases could impact their respective businesses.

Pfizer Helped Save the World With Covid Vaccines. Now It Needs to Right Itself. The company is pulling back on some of its research programs and laying off workers after overestimating pandemic ...

Kansas Attorney General Kris Kobach sued Pfizer over marketing surrounding its COVID-19 vaccine. The company said the legal challenge is without merit.

Pfizer CEO Albert Bourla on Thursday said pharmaceutical companies will likely take legal action against Medicare drug price negotiations, which aim to cut costs for older Americans, but will ...